RxDoctor Payments DataLook up a doctor →

CABLIVI: payments to doctors

Payments that named CABLIVI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.8M
Providers
4,823
Transactions
9,726
Average per transaction
$189

The per-transaction average — $189 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,823 providers the average total is $380, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Sanofi$1,791,58097.7%
Sanofi-aventis U.S. LLC$37,5782.0%
Bioverativ Therapeutics Inc.$3,1050.2%
Sanofi US Services Inc.$1,8730.1%
← All drugs & devices